http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111893045-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-73
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M23-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-46
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
filingDate 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111893045-B
titleOfInvention In Vitro Model of Central Nervous System Intoxication and Method for Evaluating the Efficacy of Heavy Activators
abstract The invention belongs to the field of medicine, and specifically relates to a method for establishing an in vitro model of central nervous system organophosphorus compound poisoning, comprising the following steps: (1) obtaining a transwell in vitro blood-brain barrier model; (2) adding a concentration of 0.065 to 0.20 mg/ml The acetylcholinesterase solution and the organophosphorus compound solution with a volume percentage concentration of 0.5× 10-8-10-3 were sequentially added to the lower pool of the transwell in vitro blood - brain barrier model at a volume ratio of (1-10):1, and left to stand for 1 to 10 minutes to obtain an in vitro model of central nervous system organophosphorus compound poisoning. The invention also relates to a method for evaluating the efficacy of the acetylcholinesterase reactivator in vitro. The in vitro model of the invention effectively simulates the poisoning of the organophosphorus compound in the central nervous system, and the evaluation method of the invention can accurately and rapidly evaluate the curative effect of the acetylcholinesterase heavy activator.
priorityDate 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ86GC8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO62763
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7871
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552868
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ867X2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281160
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ867X3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226091
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114549
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6254
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9DDE3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449360618
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280794
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2246
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID607724
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164921
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21836
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAA68151
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP56161
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ92081
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB4FZ87
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07692
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ869C3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454560181
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25317
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID444686
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID113580815
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5G2QVL5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553254
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO42275
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429549097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547315
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID462158
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ92035
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID393733
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100005469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153978341
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83817
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14164
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396388
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP37136
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14268
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29499
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27677
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25661
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ86GC9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04058
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID489828
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11423
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID740018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4766
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396133
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7LZG1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451832691

Total number of triples: 87.